Desh Rakshak Aushdhalaya Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 351394, "name": "Desh Rakshak", "stock_name": "Desh Rakshak", "full_name": "Desh Rakshak Aushdhalaya Ltd", "name_url": "stocks-analysis/desh-rakshak", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "24.55", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "24.55", "mcapval": "15.00 Cr", "mcap": "Micro Cap", "scripcode": 531521, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE971E01016", "curr_date": "Apr 10", "curr_time": "", "bse_nse_vol": "1.1 k", "exc_status": "Active", "traded_date": "Apr 10, 2026", "traded_date_str": "2026 04 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/desh-rakshak-351394-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Desh Rakshak Aushdhalaya Ltd Drops 9.07% Amid Valuation Upgrade and Mixed Fundamentals", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-drops-907-amid-valuation-upgrade-and-mixed-fundamentals-3943266", "imagepath": "", "date": "2026-04-12 09:00:38", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>06 Apr:</strong> Stock opens at Rs.27.00, flat through initial days</p>\n <p><strong>09 Apr:</strong> MarketsMOJO upgrades rating to Sell on valuation improvement</p>\n <p><strong>10 Apr:</strong> Stock closes at Rs.24.55, down 4.66% on heavy volume</p>\n <p><strong>Weekly Summary:</strong> Stock down 9.07% vs Sensex up 5.34%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.27.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.24..." }, { "title": "Desh Rakshak Aushdhalaya Ltd Upgraded to Sell on Improved Valuation Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/desh-rakshak-aushdhalaya-ltd-upgraded-to-sell-on-improved-valuation-metrics-3941109", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DeshRakshakAush_mojoScore_3941109.png", "date": "2026-04-10 08:26:11", "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 9 April 2026. This change is primarily driven by a significant improvement in valuation metrics, even as the company’s financial performance remains largely flat and operational challenges persist." }, { "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-renewed-price-attractiveness-3940777", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DeshRakshakAush_valuationdot_3940777.png", "date": "2026-04-10 08:00:17", "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite a recent day decline of 4.89%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling entry points compared to both historical levels and peer averages, signalling a potential reappraisal by investors." }, { "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shift Signals Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shift-signals-renewed-price-attractiveness-3895526", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DeshRakshakAush_valuationdot_3895526.png", "date": "2026-03-17 08:00:25", "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from very attractive to attractive territory. Despite a challenging year-to-date performance and a Strong Sell mojo grade, the stock’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a potential value opportunity relative to its peers and historical benchmarks." }, { "title": "Desh Rakshak Aushdhalaya Ltd Falls to 52-Week Low Amidst Continued Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-falls-to-52-week-low-amidst-continued-underperformance-3869949", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DeshRakshakAush_priceRelatedfactors_3869949.png", "date": "2026-03-04 12:44:08", "description": "Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today at Rs.23.16, marking a significant decline amid broader market fluctuations. The stock’s performance continues to trail its sector and benchmark indices, reflecting ongoing pressures on its valuation and financial metrics." }, { "title": "Desh Rakshak Aushdhalaya Ltd Falls 9.74%: 3 Key Factors Driving the Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-falls-974-3-key-factors-driving-the-decline-3862675", "imagepath": "", "date": "2026-02-28 17:02:23", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Stock hits 52-week low at Rs.25.65 amid market underperformance</p>\n <p><strong>24 Feb:</strong> Downgrade to Strong Sell by MarketsMOJO due to technical weakness and flat financials</p>\n <p><strong>27 Feb:</strong> New 52-week low of Rs.24.37 as selling pressure intensifies</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.27.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.24.37</div><div class=\"stat-change negative\">-9.74%</..." }, { "title": "Desh Rakshak Aushdhalaya Ltd Falls to 52-Week Low Amidst Continued Market Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-falls-to-52-week-low-amidst-continued-market-pressure-3860346", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DeshRakshakAush_priceRelatedfactors_3860346.png", "date": "2026-02-27 12:20:27", "description": "Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.24.37 on 27 Feb 2026, marking a significant decline amid broader market weakness and sector underperformance." }, { "title": "Desh Rakshak Aushdhalaya Ltd Downgraded to Strong Sell Amid Technical Weakness and Flat Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/desh-rakshak-aushdhalaya-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-flat-financials-3852368", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DeshRakshakAush_mojoScore_3852368.png", "date": "2026-02-24 08:35:20", "description": "Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 23 February 2026. This revision reflects deteriorating technical indicators, a cautious financial trend, and a nuanced valuation profile, signalling heightened risks for investors despite some attractive valuation metrics." }, { "title": "Desh Rakshak Aushdhalaya Ltd Hits 52-Week Low Amidst Market Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-hits-52-week-low-amidst-market-underperformance-3851419", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DeshRakshakAush_priceRelatedfactors_3851419.png", "date": "2026-02-23 10:46:04", "description": "Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today, with its stock price falling to Rs. 25.65. This marks a significant decline amid a broader market environment where the Sensex continues to show resilience." } ], "total": 207, "sid": "351394", "stock_news_url": "https://www.marketsmojo.com/news/desh-rakshak-aushdhalaya-351394" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Change in RTA", "datetime": "15-Apr-2026", "details": "Intimation regarding change in RTA pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015", "source": "BSE" }, { "caption": "Intimation Pursuant To Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "15-Apr-2026", "details": "Intimation regarding Re-appointment of Internal Auditor pursuant to Regulation 30 of the SEBI (LODR) Reg 2015", "source": "BSE" }, { "caption": "Intimation Pursuant To Regulation 30 Read With Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "15-Apr-2026", "details": "Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

06 Apr: Stock opens at Rs.27.00, flat through initial days

09 Apr: MarketsMOJO upgrades rating to Sell on valuation improvement

10 Apr: Stock closes at Rs.24.55, down 4.66% on heavy volume

Weekly Summary: Stock down 9.07% vs Sensex up 5.34%

Read full news article

Desh Rakshak Aushdhalaya Ltd Upgraded to Sell on Improved Valuation Metrics

2026-04-10 08:26:11

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 9 April 2026. This change is primarily driven by a significant improvement in valuation metrics, even as the company’s financial performance remains largely flat and operational challenges persist.

Read full news article

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-04-10 08:00:17

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite a recent day decline of 4.89%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling entry points compared to both historical levels and peer averages, signalling a potential reappraisal by investors.

Read full news article

Desh Rakshak Aushdhalaya Ltd Valuation Shift Signals Renewed Price Attractiveness

2026-03-17 08:00:25

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from very attractive to attractive territory. Despite a challenging year-to-date performance and a Strong Sell mojo grade, the stock’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a potential value opportunity relative to its peers and historical benchmarks.

Read full news article

Desh Rakshak Aushdhalaya Ltd Falls to 52-Week Low Amidst Continued Underperformance

2026-03-04 12:44:08

Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today at Rs.23.16, marking a significant decline amid broader market fluctuations. The stock’s performance continues to trail its sector and benchmark indices, reflecting ongoing pressures on its valuation and financial metrics.

Read full news article

Desh Rakshak Aushdhalaya Ltd Falls 9.74%: 3 Key Factors Driving the Decline

2026-02-28 17:02:23

Key Events This Week

23 Feb: Stock hits 52-week low at Rs.25.65 amid market underperformance

24 Feb: Downgrade to Strong Sell by MarketsMOJO due to technical weakness and flat financials

27 Feb: New 52-week low of Rs.24.37 as selling pressure intensifies

-9.74%Read full news article

Desh Rakshak Aushdhalaya Ltd Falls to 52-Week Low Amidst Continued Market Pressure

2026-02-27 12:20:27

Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.24.37 on 27 Feb 2026, marking a significant decline amid broader market weakness and sector underperformance.

Read full news article

Desh Rakshak Aushdhalaya Ltd Downgraded to Strong Sell Amid Technical Weakness and Flat Financials

2026-02-24 08:35:20

Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 23 February 2026. This revision reflects deteriorating technical indicators, a cautious financial trend, and a nuanced valuation profile, signalling heightened risks for investors despite some attractive valuation metrics.

Read full news article

Desh Rakshak Aushdhalaya Ltd Hits 52-Week Low Amidst Market Underperformance

2026-02-23 10:46:04

Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today, with its stock price falling to Rs. 25.65. This marks a significant decline amid a broader market environment where the Sensex continues to show resilience.

Read full news article

View All News